Since the nuclear catastrophes of Hiroshima and Nagasaki, August 1945.
There has been only one major therapeutic action for the
treatment of victims of nuclear catastrophe.
FRANCE DISTRIBUTES IODINE NEAR REACTORS
French governmental agencies will distribute ".... potassium iodide (KI) tablets to approximately 600,000 people living within 10 kilometers [6 miles] of 24 nuclear installation...
In the event of a nuclear accident, the residents would take the tablets to saturate their thyroid
glands with a stable isotope of iodine to block the uptake of radioactive iodine isotopes, byproducts of
nuclear fission, which
can cause thyroid cancer."
[Science Vol. 275, 28 March 1997]
U.S.A. - ZERO ACTION
This action by France by far eclipses the record of the U.S. government in
developing a therapy
for the treatment of victims exposed to an uncontrolled nuclear reaction.
SPLEEN FACTOR
However a factor was isolated from spleen which has the potential for treating victims of a nuclear radiation
catastrophe and also cancer patients subjected to radiation therapy.